N-(4-(7-hydroxy-4-oxo-4H-chromen-3-yl)phenyl)-2-(p-tolyloxy)acetamide

ID: ALA3594029

Chembl Id: CHEMBL3594029

PubChem CID: 122182343

Max Phase: Preclinical

Molecular Formula: C24H19NO5

Molecular Weight: 401.42

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1ccc(OCC(=O)Nc2ccc(-c3coc4cc(O)ccc4c3=O)cc2)cc1

Standard InChI:  InChI=1S/C24H19NO5/c1-15-2-9-19(10-3-15)29-14-23(27)25-17-6-4-16(5-7-17)21-13-30-22-12-18(26)8-11-20(22)24(21)28/h2-13,26H,14H2,1H3,(H,25,27)

Standard InChI Key:  IEUZVBLBCDSYLB-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3594029

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 401.42

Molecular Weight (Monoisotopic): 401.1263

AlogP: 4.49

#Rotatable Bonds: 5

Polar Surface Area: 88.77

Molecular Species: ACID

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 6.48

CX Basic pKa: ┄

CX LogP: 4.30

CX LogD: 3.36

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.51

Np Likeness Score: -0.46

References

1. Wang W, He Y, Xu P, You Q, Xiao H, Xiang H..  (2015)  Synthesis and biological evaluation of isoflavone amide derivatives with antihyperlipidemic and preadipocyte antiproliferative activities.,  23  (15): [PMID:26145818] [10.1016/j.bmc.2015.06.032]

Source

Source(1):

• Scientific Literature